|
Video: What is a Stock Split?
|
|
Acer Therapeutics is a biopharmaceutical company developing a personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis as well as other autoimmune diseases such as neuromyelitis optica (NMO). Co. has been developing OPX-212 as an autologous T-cell immunotherapy for the treatment of NMO. NMO is an autoimmune disorder in which immune system cells and antibodies attack astrocytes causing to the secondary destruction of nerve cells (axons) in the optic nerves and the spinal cord. OPX-212 is specifically tailored to each patient's immune response to a protein, aquaporin-4 expressed by astrocytes, which is the targeted antigen in NMO. According to our OPXA split history records, OPXA has had 4 splits. | |
|
OPXA (OPXA) has 4 splits in our OPXA split history database. The first split for OPXA took place on June 19, 2006. This was a 1 for 10 reverse split, meaning for each 10 shares of OPXA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. OPXA's second split took place on December 17, 2012. This was a 1 for 4 reverse split, meaning for each 4 shares of OPXA owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 25 share position following the split. OPXA's third split took place on April 14, 2004. This was a 1 for 50 reverse split, meaning for each 50 shares of OPXA owned pre-split, the shareholder now owned 1 share. For example, a 25 share position pre-split, became a 0.5 share position following the split. OPXA's 4th split took place on September 29, 2015. This was a 1 for 8 reverse split, meaning for each 8 shares of OPXA owned pre-split, the shareholder now owned 1 share. For example, a 0.5 share position pre-split, became a 0.0625 share position following the split.
When a company such as OPXA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OPXA split history from start to finish, an original position size of 1000 shares would have turned into 0.0625 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OPXA shares, starting with a $10,000 purchase of OPXA, presented on a split-history-adjusted basis factoring in the complete OPXA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
09/20/2017 |
|
Start price/share: |
$15.36 |
|
End price/share: |
$0.97 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.68% |
|
Average Annual Total Return: |
-54.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$631.38 |
|
Years: |
3.47 |
|
|
|
Date |
Ratio |
06/19/2006 | 1 for 10 | 12/17/2012 | 1 for 4 | 04/14/2004 | 1 for 50 | 09/29/2015 | 1 for 8 |
|
|